510(k) Report

510(k) · Cleared

Cleared

ECHELON ENDOPATH Staple Line Reinforcement

K221343510(k) TraditionalCleared Sep 16, 2022130-day reviewClass II21 CFR 878.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ethicon Endo-Surgery, LLC · OXC Mesh, Surgical, Absorbable, Staple Line Reinforcement

Cleared on Sep 16, 2022 as substantially equivalent to K190937 (Ethicon Endo-Surgery, LLC, 2019) after a 130-day review. Its family tree reaches back 8 generations to 1985. 1 later device descends from it.

Decided
Sep 16, 2022
Review
130 days
Class
Class II
Product code
OXC
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K842066 (1985). 22 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 8 generations backK842066 Peri-Guard Pericardial PatchGenetic Laboratories, Inc. · 1985
  2. 7 generations backK961811 Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 6 generations backK983162 Peri-Guard, CV Peri-Guard, Ocu-Guard, Supple Peri-Guard, Peri-Strips…Bio-Vascular, Inc. · 1998 · Recalled
  4. 5 generations backK992537 Peri-Strips-Sleeve, Peri-Strips-Strip and Peri-Strips Dry…Bio-Vascular, Inc. · 2000
  5. 4 generations backK014183 Afb (Absorbable Foam Buttress)J&J Corporate Biomaterials Center · 2002
  6. 3 generations backK030782 Seamguard Bioabsorbable Staple Line Reinforcement MaterialW. L. Gore & Associates, Inc. · 2003
  7. 2 generations backK032865 Gore Seamguard Bioabsorbable Staple Line Reinforcement MaterialW. L. Gore & Associates, Inc. · 2003
  8. 1 generation backK190937 Echelon Endopath Staple Line ReinforcementEthicon Endo-Surgery, LLC · 2019
  9. This deviceK221343 ECHELON ENDOPATH Staple Line ReinforcementEthicon Endo-Surgery, LLC · 2022
  10. Descendant · cites it directly · 0 of its ownK252906 ECHELON ENDOPATH Staple Line Reinforcement (ECH60R)Ethicon Endo-Surgery, LLC · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252906ECHELON ENDOPATH Staple Line Reinforcement (ECH60R)Ethicon Endo-Surgery, LLC · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K842066Peri-Guard Pericardial PatchGenetic Laboratories, Inc.1985—
−7K961811Peri-Guard PericardiumBio-Vascular, Inc.1996—
−6K983162Peri-Guard, CV Peri-Guard, Ocu-Guard, Supple Peri-Guard, Peri-Strips - Sleeve…Bio-Vascular, Inc.19982
−5K992537Peri-Strips-Sleeve, Peri-Strips-Strip and Peri-Strips Dry (Non-Naoh-Treated…Bio-Vascular, Inc.2000—
−4K014183Afb (Absorbable Foam Buttress)J&J Corporate Biomaterials Center2002—
−3K030782Seamguard Bioabsorbable Staple Line Reinforcement MaterialW. L. Gore & Associates, Inc.2003—
−2K032865Gore Seamguard Bioabsorbable Staple Line Reinforcement MaterialW. L. Gore & Associates, Inc.2003—
−1K190937Echelon Endopath Staple Line ReinforcementEthicon Endo-Surgery, LLC2019—
0 (this device)K221343ECHELON ENDOPATH Staple Line ReinforcementEthicon Endo-Surgery, LLC2022—
+1K252906ECHELON ENDOPATH Staple Line Reinforcement (ECH60R)Ethicon Endo-Surgery, LLC2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199230
199310
199420
199640
199710
199910
200010
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K221343, 1985–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OXC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OXC device

  1. #1 K252906 ECHELON ENDOPATH Staple Line Reinforcement…score 13.0 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K190937Echelon Endopath Staple Line Reinforcement
Summary page 4
…79, General and Plastic Surgery Predicate Device Echelon Endopath Staple Line Reinforcement cleared under K190937 Reference Device Intuitive Surgical SureFormTM 60 and SureFormTM 60 Reloads clea…
Ethicon Endo-Surgery, LLC2019—
†K173721SureForm 60 and SureForm 60 ReloadsIntuitive Surgical20183

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252906ECHELON ENDOPATH Staple Line Reinforcement (ECH60R)Ethicon Endo-Surgery, LLC20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 37 years and passes through 5 companies; a new generation was cleared every 2.3 years on median.
  • 3 of the 22 ancestors have a recall of any class.
  • Of its descendants, K252906 (Ethicon Endo-Surgery, LLC, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All OXC devices

OXC Mesh, Surgical, Absorbable, Staple Line Reinforcement: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · OXC

1in 2023

2013: 22015: 12018: 12019: 12022: 22023: 12026 (partial year): 1
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OXC

Too few OXC 510(k)s in any year since 2007 to give a median.

Recalls per year · OXC

No recall names OXC since 2007.

Adverse event reports per year · OXC

45in 2025

2018: 42020: 42021: 332022: 1642023: 262024: 382025: 45
2007high 164 (2022) · low 0 (2007)2025

MAUDE reports naming product code OXC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20132—00
20140—00
20151—00
20160—00
20170—00
20181—04
20191—00
20200—04
20210—033
20222—0164
20231—026
20240—038
20250—045
20261—0—

What is it indicated for?

ECHELON ENDOPATH Staple Line Reinforcement is indicated for use in surgical procedures in which soft tissue transection or resection with staple line reinforcement is needed. ECHELON ENDOPATH Staple Line Reinforcement can be used for reinforcement of staple lines during lung resection and bariatric surgical procedures. The device can also be used for reinforcement of staple lines during gastric, small bowel, and colorectal procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K221343: ECHELON ENDOPATH Staple Line Reinforcement.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K221343

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026